RetinalGenix Technologies Inc. RTGN
OTC · OOTC · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2022-01-07
RetinalGenix Technologies Inc. statistics & valuation
Market cap$75.4M
Market cap as of 2026-06-30. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Return on assets | -11542.2% | -28909.6% | -1340313.5% | -1331289.1% | -44052.8% | -3402.4% |
| Return on equity | 105.5% | 295.4% | 148.7% | 366.1% | 469.0% | 2586.0% |
| Current ratio | 0.01 | 0.00 | 0.00 | — | — | — |
Source: SEC EDGAR filings · CIK 0001836295 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.